...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: My general impressions

I think it's because there is so much demand for participants in the USA and Canada due to the large number of trials companies have to look elsewhere to get suffcient numbers. It's simply a matter of competition for suitable patients.

Share
New Message
Please login to post a reply